Skip to main content
letter
. 2024 Oct 28;8(11):e70030. doi: 10.1002/hem3.70030

Figure 1.

Figure 1

Detection and quantification of circulating erythroid cells retaining mitochondria by flow cytometry in SS, SC patients, and AA healthy individuals. (A) Flow cytometry gating strategy of CD71/TO and/or MitoTracker Deep Red (MTKDR) staining. (B) Percentage of total (i) and stress (ii) reticulocytes in SS, SC patients, and AA healthy individuals and total (iii) and stress (iv) reticulocytes in SS patients treated or not with HU. (C) Percentage of mitochondria retention in total (i) and stress (ii) reticulocytes in SS, SC patients, and AA healthy individuals and in total (iii) and stress (iv) reticulocytes in SS patients treated or not by HU. (D) Mitochondria retention in mature RBCs in SS and SC patients and in AA controls (i) and in SS patients treated or not with HU (ii).